Patents for A61P 35 - Antineoplastic agents (221,099)
11/2010
11/10/2010EP1653944B1 Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors
11/10/2010EP1569692B1 Betaine and salicylic acid compositions
11/10/2010EP1513589B1 1,5-disubstituted pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma
11/10/2010EP1460995B1 Transdermal transport of compounds
11/10/2010EP1401433B1 Azole acid derivatives, alone or in combination, for treating diabetes and dyslipidemias; and for treating malignant diseases
11/10/2010EP1265915B1 Novel compounds
11/10/2010CN1989991B Process for preparing rhodiola root extract
11/10/2010CN1973902B Anticancer medicine adriamycin composition with ginseng polyse as carrier and its preparation process
11/10/2010CN1943661B A Chinese traditional medicinal composition and its preparation method
11/10/2010CN1927387B Application of interleukins-15 in preparation of medicine for tumor immunization therapy and immunotherapy drug
11/10/2010CN1895676B Prodrug of taxol or polyene-taxol with carbowax as carrier
11/10/2010CN1874781B Compositions of botanical extracts for cancer therapy
11/10/2010CN1864665B Method for preparation of drug-encapsulating polymer micelle
11/10/2010CN1861041B Temp-sensitive, slow-releasing gel used for local injection, and its preparation method
11/10/2010CN1853694B Medicinal composition for treating leukemia
11/10/2010CN1775946B Enhanced virus-mediated DNA transfer
11/10/2010CN1706371B Efficient sword-like iris seed preparation and its preparation process
11/10/2010CN1561208B Methods to mobilize progenitor/stem cells
11/10/2010CN101883779A Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides
11/10/2010CN101883774A Thienopyrimidine and pyrazolopyrimidine compounds and their use as MTOR kinase and PI3 kinase inhibitors
11/10/2010CN101883767A Abcg2 inhibitor
11/10/2010CN101883765A Amorphous form of heterocyclic compound, solid dispersion and medicinal preparation each comprising the same, and process for production of the same
11/10/2010CN101883764A Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases
11/10/2010CN101883578A Use of VEGFR-2 inhibitors for treating metastatic cancer
11/10/2010CN101883577A Combination therapy for pancreatic cancer using an antigenic peptide and chemotherapeutic agent
11/10/2010CN101883557A Novel thermosensitive liposomes containing therapeutic agents
11/10/2010CN101880873A Preparation process of 103Pd sealed seed source core
11/10/2010CN101880701A New method for preparing aprotinin derivatives by using methanol yeast
11/10/2010CN101880688A Method for selectively replicating replication-defective adenovirus and application
11/10/2010CN101880640A Klebsiella pneumoniae (Mannose-sensitive hemagglutination) pilus strain
11/10/2010CN101880381A Segmented copolymer modified by polyethylene glycol 1000 vitamin E succinic acid ester, preparation method and applications thereof
11/10/2010CN101880327A Scorpion arialgesic anti-tumoral peptide fusion and acquisition method thereof
11/10/2010CN101880310A Split heterocyclic 23-hydroxybetulinic acid derivatives and preparation method, preparation and application thereof
11/10/2010CN101880308A New hopane-type triterpene and preparation method and application thereof
11/10/2010CN101880306A Stauntonia brachyanthera Hand-Mazz saponins components as well as preparation method and application thereof
11/10/2010CN101880305A Preparation method of ginsenoside metabolin M1 fatty acid ester compound
11/10/2010CN101880304A 24(R)-pseudoginsenoside-GQ as well as semisynthesis method and medicinal application thereof
11/10/2010CN101880284A Chemical synthesis method of Epothilone B-lactam derivative
11/10/2010CN101880283A Azaindole kinase inhibitors
11/10/2010CN101880281A Thiophane nucleoside analogues and preparation method and application thereof
11/10/2010CN101880277A Aza spiro alkane derivatives as inhibitors of metallproteases
11/10/2010CN101880273A Benzo-hexahydric N-heterocyclic derivatives, preparation method and application thereof in medicines
11/10/2010CN101880269A Diterpene monomers and method for separating and preparing diterpene monomers from Clerodendron cyrtophyllum Turcz
11/10/2010CN101880265A Acid-sensitive polymeric micelle pharmaceutical composition and preparation method thereof
11/10/2010CN101880222A Square acid derivate and preparation method thereof
11/10/2010CN101879427A Doxorubicin hydrochloride-carrying natural polymer-poly(3-benzene acid acrylamide) composite nanospheres, manufacturing method and application thereof
11/10/2010CN101879316A Genetic engineering vaccine as well as preparation method and application thereof in pharmacy
11/10/2010CN101879315A Polymalic acid prodrug derivant and applications thereof
11/10/2010CN101879313A Anti-tumor nano prodrug system based on dendrimer and preparation method thereof
11/10/2010CN101879305A Application of serum thymic factors to preparation of anti-tumor medicine and protection medicine of tumor physical and chemical treatment medicine
11/10/2010CN101879265A Process for co-producing total saponins and polysaccharide from star-of-Bethlehem
11/10/2010CN101879257A Traditional Chinese medicine for treating tumors
11/10/2010CN101879244A Traditional Chinese medicine for treating cerebral tumors
11/10/2010CN101879215A Application of schisandra lignan component in preparing anti-lung cancer medicament
11/10/2010CN101879204A Anticancer effective part of Korean folk medicament Artemisia sacrorum Ledeb. and preparation method thereof
11/10/2010CN101879202A Novel application of Java brucea fruit oil emulsion injection to anticancer aspect
11/10/2010CN101879191A Medicinal composition
11/10/2010CN101879180A New pharmacologic application of aloe polysaccharide
11/10/2010CN101879173A Application of Corilagin in preparing anti-tumor drugs
11/10/2010CN101879170A Anti-tumor application of malonyl astragaloside I and aglycon thereof
11/10/2010CN101879160A Application of 3-substituted aryl oxindole in multidrug resistance tumor cells
11/10/2010CN101879159A Application of 3,5-dimethylpsoralen in preparing anti-tumor medicaments
11/10/2010CN101879156A Medicinal composition and application thereof
11/10/2010CN101879144A Pirarubicin or pirarubicin hydrochloride liposome freeze-drying agent and preparation method thereof
11/10/2010CN101879138A Vinca alkaloid nano emulsion injection and preparation method thereof
11/10/2010CN101879137A Method for preparing stealth liposome
11/10/2010CN101708197B Soft capsule preparation of oleum fructus brucease and novel process thereof
11/10/2010CN101643750B Construction method and applications of targeting oncolytic-adenovirus carier Ad-TD-gene
11/10/2010CN101569720B Miao Nationality drug for treating leukemia
11/10/2010CN101474173B Application of cumarin coumpound Murraya jasminorage ketone in preparing anti-tumor medicament
11/10/2010CN101455845B PEG-decorated phospholipid derivative using octreotide as target ligand and production method thereof
11/10/2010CN101455652B Use of diterpenoids from Isodon japonica var.galaucocalyx in preparing anti-cancer medicine
11/10/2010CN101439188B Polymer lyophilized preparation of insoluble anti-tumor medicament
11/10/2010CN101422619B New method for preventing tumor cell growth based on nucleus binding-protein gene silencing
11/10/2010CN101401944B Method of preparing iodine-125 sealing seed source core
11/10/2010CN101381374B Pyrazinetin dicarboxylate coordination compound, preparation method thereof and use
11/10/2010CN101318946B Dimeric ainsliaea terpene A, preparation and application thereof
11/10/2010CN101292980B Pharmaceutical combination containing rapamycin for treating large intestine cancer
11/10/2010CN101279967B Medicinal composition of trimethyl xanthone-4-acetic acid for treating cancer and use thereof
11/10/2010CN101265301B Panax japonicus polysaccharides, preparation method and use thereof
11/10/2010CN101235364B Newcastle disease virus D90 strain and application thereof
11/10/2010CN101120958B Medicinal preparation for treating liver cancer and leukemia and producing technology thereof
11/10/2010CN101104031B Internal-applied traditional Chinese medicine composition for treating nasopharyngeal cancer
11/10/2010CN101104006B Method for preparing Chinese caterpillar fungus extracting concentrated liquid and application thereof
11/10/2010CN101099566B Lactucin and its preparation method and application
11/10/2010CN101073611B Medicinal composition for preventing tumor
11/10/2010CN101015680B Use of F-Glucoside peptide in preparing medicine for treating tumour
11/09/2010US7829693 Compositions and methods for inhibiting expression of a target gene
11/09/2010US7829683 Polynucleotides encoding modified HIV-1 gp41 membrane polypeptides
11/09/2010US7829675 TWEAK receptor
11/09/2010US7829670 Filamin A interacting protein 1 for use in directed destruction of actin binding protein filamin-1; treating neurodegenerative disorders
11/09/2010US7829596 administering to the patient an effective amount of a xanthine oxidase inhibitor ( allopurinol, 7,8-dihydroneopterin, 5,6,7,8-tetrahydrobiopterin, leukopterin, xanthopterin, neopterin etc.) to reduce sympathetic nervous system activity and/or improving cardiovascular reflex status for treating cachexia
11/09/2010US7829591 Nymphaeol-A, nymphaeol-B and nymphaeol-C; microbiocide, antitumor agent, food, beverage and cosmetic preservative; antioxidant food supplement
11/09/2010US7829573 Therapeutic combinations of antihypertensive and antiangiogenics agents
11/09/2010US7829570 Substituted 4-amino isoxazolo[5,4-d]pyrimidines as kinase inhibitors
11/09/2010US7829561 interleukin-1B converting enzyme inhibitors such as 3-(6,11-Dioxo-1,2,3,4-tetrahydro-pyridazino[1,2-b]phthalazin-1-carboxamido)-5-fluoro-4-oxo-pentanoic acid, that mediate cell apoptosis and inflammation, used for cell or organ preservation and the treatment of osteoarthritis and rheumatoid arthritis
11/09/2010US7829558 Fused ring heterocycle kinase modulators
11/09/2010US7829534 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
11/09/2010US7829531 monoclonal antibody conjugated with peptide drug such as dolastatin derivative
11/09/2010US7829529 Use of factor VIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis